Navigation Links
UK junior doctors gaining less experience of common procedures
Date:8/20/2007

hemselves, on the grounds that they will be faster, so minimising the risk of missing waiting time targets.

But whatever the reasons, the decline in practical experience needs to be addressed, to ensure that junior doctors are appropriately trained and continue to provide a much needed resource in emergency care, the authors conclude.


'/>"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ Specialty Journals
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Nurses competing with junior doctors in some assessments
2. Junior Doctors Working Long Hours May Perform Poorly
3. MP Junior Doctors Continue Strike
4. Junior Doctors Put An End To Strike
5. Andhra Junior Doctors Call Off Strike Partially; To Attend Emergency cases
6. Parents of Junior Athletes do More Harm than Good
7. Crazy Things - Children aged five joining junior gym
8. Junior Medicos Call Off Hunger Strike
9. Several Junior Doctors Could Be Rendered Jobless
10. Junior Doctors Back To Work
11. Junior Doctors In Madhya Pradesh Strike Work
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 1COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 2Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 1Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 1Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 4